Issues
Areas
Solutions
TRL Level
SRL Level
The LIS-platform, a BIM-based software platform, is being developed to monitor various aspects of buildings. This platform provides a comprehensive overview of structu...
A rapid biosensor for detecting Campylobacter in under 10 minutes, offering instant results via Bluetooth. This breakthrough addresses climate-related health risks and food safety, outpacing current diagnostic methods.
- Current technologies for foodborne pathogen screening require labor-intensive sample enrichment steps, pathogen isolation and purification, and costly readout machinery.
- A point-of-care diagnostic with a potential application across the food value chain will be developed for the rapid (<3 min), in-situ detection of the most prevalent foodborne pathogen Campylobacter spp. with online registration capacity.
Addresses: Droughts, Multi-hazards
See more information about this level and the TRL and SRL levels.
The market assessment of this innovation has been self-declared by the provider and has not been independently verified. For more details, please contact the innovator directly.
Our innovation is a rapid biosensor designed to detect Campylobacter, a major cause of foodborne illness, in less than 10 minutes. This device is specifically engineered for real-time, in-situ monitoring across the food value chain, ensuring prompt detection of this pathogen. Unlike traditional methods that require extensive processing and time, our biosensor offers instant results via Bluetooth to a smartphone interface, making it highly accessible and user-friendly. The device meets WHO’s ASSURED criteria (Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment free, and Deliverable), addressing the critical need for quick, accurate diagnostics in urban environments where climate change exacerbates food safety risks. This breakthrough enhances public health management by providing immediate, reliable data, enabling timely intervention and reducing the incidence of Campylobacter-related illnesses.
Our technology, the Bioelectric Recognition Assay (BERA)-class bioelectric biosensors based on membrane-engineered cells, can respond to very low concentrations of an analyte (e.g., protein, pathogen) with extreme speed, specificity, and sensitivity. Cells-on-a-chip are engineered to bear target-specific antibodies on their surface. Upon binding the target, potential changes in the cell membrane produce a strong bioelectric signal. This technology has been developed and validated by the core team members through several national and EU-funded projects and is EPO-granted.
Our co-founders have been working in three distinct areas of medical/biotech diagnostics R&D and industry: (a) as university researchers with cumulative experience of 20+ years in developing pre-commercial and commercial systems, (b) as founders and executive officers of a diagnostics start-up (EMBIO Diagnostics Ltd, Nicosia, CY), and (c) as end-users/customers of routine diagnostic products in clinical practice. Therefore, their combined expertise covers the entire chain from R&D to production to customer need specification.
Cell-based consumables have a relatively short storability but we are working on the prolongation of cell viability by the use of custom-made bio-hydrogels.
A rapid biosensor for detecting Campylobacter in under 10 minutes, offering instant results via Bluetooth. This breakthrough addresses climate-related health risks and food safety, outpacing current diagnostic methods.
- Current technologies for foodborne pathogen screening require labor-intensive sample enrichment steps, pathogen isolation and purification, and costly readout machinery.
- A point-of-care diagnostic with a potential application across the food value chain will be developed for the rapid (<3 min), in-situ detection of the most prevalent foodborne pathogen Campylobacter spp. with online registration capacity.
Addresses: Droughts, Multi-hazards
The business plan for this innovation has been evaluated by The Funding Company and it is considered to be ready for investment.
The main components of the system have been tested separately, and an initial integration exercise has been conducted.
Our innovation is a rapid biosensor designed to detect Campylobacter, a major cause of foodborne illness, in less than 10 minutes. This device is specifically engineered for real-time, in-situ monitoring across the food value chain, ensuring prompt detection of this pathogen. Unlike traditional methods that require extensive processing and time, our biosensor offers instant results via Bluetooth to a smartphone interface, making it highly accessible and user-friendly. The device meets WHO’s ASSURED criteria (Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment free, and Deliverable), addressing the critical need for quick, accurate diagnostics in urban environments where climate change exacerbates food safety risks. This breakthrough enhances public health management by providing immediate, reliable data, enabling timely intervention and reducing the incidence of Campylobacter-related illnesses.
Our technology, the Bioelectric Recognition Assay (BERA)-class bioelectric biosensors based on membrane-engineered cells, can respond to very low concentrations of an analyte (e.g., protein, pathogen) with extreme speed, specificity, and sensitivity. Cells-on-a-chip are engineered to bear target-specific antibodies on their surface. Upon binding the target, potential changes in the cell membrane produce a strong bioelectric signal. This technology has been developed and validated by the core team members through several national and EU-funded projects and is EPO-granted.
Our co-founders have been working in three distinct areas of medical/biotech diagnostics R&D and industry: (a) as university researchers with cumulative experience of 20+ years in developing pre-commercial and commercial systems, (b) as founders and executive officers of a diagnostics start-up (EMBIO Diagnostics Ltd, Nicosia, CY), and (c) as end-users/customers of routine diagnostic products in clinical practice. Therefore, their combined expertise covers the entire chain from R&D to production to customer need specification.
Not a member yet?
No worries, you can register here.
Name field No Space Allowed.
Already a member? login here
Not a member yet?
No worries, you can register here.
You know what they say, sharing is caring! You can share this innovation with as many people you feel will be interested in it.
Tip: include a message about why it caught your eye.
Did something peak your interest? You can share any questions, praises, comments, or concerns and the company will recieve them directly. No need for middle-men here.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
